CDKN2A variants in a population-based sample of queensland families with melanoma

被引:159
|
作者
Aitken, J [1 ]
Welch, J [1 ]
Duffy, D [1 ]
Milligan, A [1 ]
Green, A [1 ]
Martin, N [1 ]
Hayward, N [1 ]
机构
[1] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
来源
关键词
D O I
10.1093/jnci/91.5.446
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Mutations in the CDKN2A gene confer susceptibility to cutaneous malignant melanoma (CMM); however, the population incidence of such mutations is unknown, Polymorphisms in CDKN2A have also been described, but it is not known whether they influence melanoma risk, We investigated the association of CDKN2A mutations and polymorphisms nifh melanoma risk in a population-based sample of families ascertained through probands with melanoma, Methods: The 482 Queensland, Australia, families in our sample were characterized previously as having high, intermediate, or low family risk of CMM. Unrelated individuals (n = 200 families/individuals) drawn from the Australian Twin Registry served as control subjects. For individuals in the high-risk group, the entire CDKN2A gene coding region was screened for mutations by use of the polymerase chain reaction, agarose gel electrophoresis, allele-specific oligonucleotide (ASO) hybridization, and single-strand conformation polymorphism analysis, The intermediate- and low-risk families and control subjects were analyzed by ASO hybridization for a total of six recurring mutations as well as for polymorphisms at nucleotides (Nts) 442, 500, and 540, Results: CDKN2A mutations were found only in the high-risk families (nine [10.3%] of 87), The prevalence of the Nt500G (guanosine) polymorphism increased linearly with increasing familial risk (two-sided P = .02) and was highest in the nine (primarily Celtic) families with CDKN2A mutations. After adjustment for ethnic origin, the relationship between risk group and the frequency of the Nt500G allele was weakened (P = .25); however, there was no relationship between ethnic origin and Nt500-polymorphism frequency among the control subjects. Conclusions: CDKN2A mutations are rare in this population (approximately 0.2% of all melanoma cases in Queensland) and appear to be associated with melanoma in only the most affected families, The Nt500G allele appears to be associated with familial risk, but this association probably reflects Celtic ancestry.
引用
收藏
页码:446 / 452
页数:7
相关论文
共 50 条
  • [31] CDKN2A mutations in Scottish families with cutaneous melanoma:: results from 32 newly identified families
    Lang, J
    Boxer, M
    MacKie, RM
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (06) : 1121 - 1125
  • [32] Association of MC1R variants and risk of melanoma (MM) in MM-prone families with CDKN2A mutations
    Goldstein, AM
    Landi, MT
    Tsang, S
    Fraser, MC
    Munroe, DJ
    Tucker, MA
    GENETIC EPIDEMIOLOGY, 2005, 29 (03) : 251 - 252
  • [33] Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families
    Taylor, Nicholas J.
    Mitra, Nandita
    Goldstein, Alisa M.
    Tucker, Margaret A.
    Avil, Marie-Francoise
    Azizi, Esther
    Bergman, Wilma
    Bishop, D. Timothy
    Bressac-de Paillerets, Brigitte
    Bruno, William
    Calista, Donato
    Cannon-Albright, Lisa A.
    Cuellar, Francisco
    Cust, Anne E.
    Demenais, Florence
    Elder, David E.
    Gerdes, Anne-Marie
    Ghiorzo, Paola
    Grazziotin, Thais C.
    Hansson, Johan
    Harland, Mark
    Hayward, Nicholas K.
    Hocevar, Marko
    Hoiom, Veronica
    Ingvar, Christian
    Landi, Maria Teresa
    Landman, Gilles
    Larre-Borges, Alejandra
    Leachman, Sancy A.
    Mann, Graham J.
    Nagore, Eduardo
    Olsson, Hakan
    Palmer, Jane M.
    Peric, Barbara
    Pjanova, Dace
    Pritchard, Antonia
    Puig, Susana
    van der Stoep, Nienke
    Wadt, Karin A. W.
    Whitaker, Linda
    Yang, Xiaohong R.
    Bishop, Julia A. Newton
    Gruis, Nelleke A.
    Kanetsky, Peter A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (12) : 2606 - 2612
  • [34] Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations
    Vignoli, Marina
    Scaini, Maria Chiara
    Ghiorzo, Paola
    Sestini, Roberta
    Bruno, William
    Menin, Chiara
    Gensini, Francesca
    Piazzini, Mauro
    Testori, Alessandro
    Manoukian, Siranoush
    Orlando, Claudio
    D'Andrea, Emma
    Bianchi-Scarra, Giovanna
    Genuardi, Maurizio
    MELANOMA RESEARCH, 2008, 18 (06) : 431 - 437
  • [35] Noncoding germline mutations in p16/CDKN2A in melanoma prone families
    Andrew, S
    CLINICAL GENETICS, 1999, 56 (03) : 188 - 190
  • [36] Phenocopies in melanoma-prone families with germ-line CDKN2A mutations
    Helgadottir, Hildur
    Olsson, Hakan
    Tucker, Margaret A.
    Yang, Xiaohong R.
    Hoiom, Veronica
    Goldstein, Alisa M.
    GENETICS IN MEDICINE, 2018, 20 (09) : 1087 - 1090
  • [37] Germline CDKN2A mutations in childhood melanoma
    Whiteman, DC
    Milligan, A
    Welch, J
    Green, AC
    Hayward, NK
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (19) : 1460 - 1460
  • [38] High prevalence of germline CDKN2A mutations in Slovenian cutaneous malignant melanoma families
    Hocevar, Marko
    Avbelj, Magdalena
    Peric, Barbara
    Zgajnar, Janez
    Besic, Nikola
    Battelino, Tadej
    CROATIAN MEDICAL JOURNAL, 2006, 47 (06) : 851 - 854
  • [39] Novel CDKN2A mutations detected in western Swedish families with hereditary malignant melanoma
    Erlandson, Anna
    Appelqvist, Frida
    Wennberg, Ann-Marie
    Holm, Joanna
    Enerback, Charlotta
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (06) : 1465 - 1467
  • [40] Functional analysis of CDKN2A 5'UTR variants associated with family history of melanoma
    Bisio, A.
    Nasti, S.
    Gargiulo, S.
    Provenzani, A.
    Quattrone, A.
    Inga, A.
    Bianchi-Scarra, G.
    EJC SUPPLEMENTS, 2008, 6 (09): : 124 - 124